1.Prescription Drug Product.
Journal of the Korean Medical Association 2003;46(6):478-480
No abstract available.
Prescriptions*
2.Clinical Trial of Drugs.
Journal of the Korean Medical Association 1998;41(8):806-809
No abstract available.
3.At the Beginning of KMA Center for Drug Information & Evaluation.
Journal of the Korean Medical Association 2005;48(10):926-928
No abstract available.
4.Drug Interaction-An Overview.
Journal of the Korean Medical Association 1997;40(1):6-11
No abstract available.
5.Therapeutic Equivalence and Bioequivalence.
Sang Goo SHIN ; Dong Ryul SOHN
Journal of the Korean Medical Association 1999;42(8):775-780
No abstract available.
Therapeutic Equivalency*
6.Translational and Clinical Pharmacology: Note from the new Editor-in-Chief
Translational and Clinical Pharmacology 2019;27(1):1-1
No abstract available.
Pharmacology, Clinical
7.Radiological study of primary lung cancer
Sang Don HAN ; Seung Goo SHIN ; Gae Dong RO ; In Soon WHANG
Journal of the Korean Radiological Society 1982;18(1):74-82
The incidence of primary lung cancer is increasing in our country. This presentation is an attempt to correlate a useful diagnosis with radiological findings of primary lung cancer. Histologically proved 210 cases of primary lung cancer are as follow: Epidermoid Ca. 65%, Adeno Ca. 18%, Small cell Ca. 9.5%, Large cell Ca. 2%, Unclassified Ca. 3.3%, Mucoepidermoid Ca. 2.4%, Mixed Ca. 0.5%. 3. In smoking history; 91% of epidermoid Ca, 17%of small cell Ca. 30% of adeno Ca. has smoking history. 4. In mass size; Average diameter of mass was most was5.3cm. Hilar mass was seen in 48 cases. Hilar mass was most frequent finding in small cell Ca. and the peripheral mass in adeno Ca. 5. Cavitary lung Ca. was 26 cases (12.4%) and most cases had relative thick wall and its mean thickness was 3.6mm. 6. Coexistence of pulmonary tuberculosis and lung cancer was 22 cases (10.5%), and most common in epidermoid cell Ca. as 16 cases. 7. Other findings include metastasis to lymph node, bone and other organ, and pleural effusion.
Diagnosis
;
Incidence
;
Lung Neoplasms
;
Lung
;
Lymph Nodes
;
Neoplasm Metastasis
;
Pleural Effusion
;
Smoke
;
Smoking
;
Tuberculosis, Pulmonary
8.Comparative Study of Captopril Tablets on the Bioavailability and the Time Course of Plasma Angiotensin-Converting Enzyme Inhibition.
In Jin JANG ; Joong Bok LEE ; Jae Ho EARM ; Jae Gook SHIN ; Sang Goo SHIN ; Chan Woong PARK ; Jin Suk HAN ; Suhnggwon KIM ; Jung Sang LEE
Korean Circulation Journal 1990;20(3):452-462
Captopril tablets of two different producers were tested for bioequivalence as well as therapeutic equivalence. The pharmacokinetics, the time course of plasma angiotensin-converting enzyme inhibition, and the changes of systolic and diastolic blood pressure after administration of drugs were studied. In a balanced, randomized two-way crossover design, two single doses of 50mg each of captopril were administered orally to twelve male volunteers. Peak blood levels of free captopril were observed about 0.85 hour after the dose, and practically free captopril could not be detected in blood within 8 hours. Peak free captopril levels of both compounds were almost identical(Capoten(R), 464.3ng/ml ; Capril(R), 504.6ng/ml). No statistically significant difference was identified between two compounds when area und the concentration time curve, peak level, time to peak were compared. Inhibition of plasma angiotensin-converting enzyme to blood free captopril concentration showed the hyperbolic concentration-response relationship with IC50 value of 7.4ng/ml. The area under the percent angiotensin-converting enzyme inhibition versus time curve were quite similar after administration of both drugs. The compounds were also found to be equivalent on the premise that no significant difference was detected when the time courses of systolic and diastolic blood pressure reduction were compared.
Biological Availability*
;
Blood Pressure
;
Captopril*
;
Cross-Over Studies
;
Humans
;
Inhibitory Concentration 50
;
Male
;
Pharmacokinetics
;
Plasma*
;
Tablets*
;
Therapeutic Equivalency
;
Volunteers
9.Population pharmacokinetics and bayesian feedback method for nortriptyline dosage optimisation.
Sang Goo SHIN ; Jong Inn WOO ; In Jin JANG ; Chan Woong PARK ; Jae Jin KIM ; Jin Pyo HONG ; Kyeong Hun LEE
Journal of Korean Neuropsychiatric Association 1992;31(5):884-894
No abstract available.
Nortriptyline*
;
Pharmacokinetics*
10.Detection of Minimal Lesion and Identification of Clonality in Malignant Lymphoma.
Young Shin KIM ; Chang Suk KANG ; Kyun gja HAN ; Kyo Young LEE ; Yong Goo KIM ; Won Il KIM ; Sang In SHIM
Korean Journal of Pathology 1998;32(4):298-308
The bone marrow biopsy is an integral part of the staging process in patients with malignant lymphomas. Bone marrow(BM) involvement indicates stage IV disease, but there are always a lot of cases in which clear separation is not possible when based on morphology alone. Additional difficulties are caused by morphologic discordance between the BM and the primary lymphoma. Immunohistochemical stain, mRNA in situ hybridization (ISH) for light chain restriction and polymerase chain reaction (PCR) for IgH CDR3 and TCRgamma were performed to find a minimal lesion and the clonality in formalin fixed paraffin embedded tissues of 39 primary lymphomas and corresponding BM biopsy specimens. As a result, nine morphologically negative bone marrows of 18 lymphomas were positive by PCR (Group I). Among the 6 lymphoma cases with morphologically suspicious BM involvement (Group II), one was confirmed to be positive for marrow involvement by both mRNA ISH and PCR and the other four by PCR alone. The positive bone marrows of Group I and II revealed gene rearrangement at the same site as the primary lesion, suggesting the same clonality. Thirteen of 15 lymphomas with morphologically positive BM (Group III) had the same clonality in the primary lymphomas and the BM lesion. Three cases among the Group III with morphologic discordance also revealed the same clonality by PCR. This study shows that a combination of mRNA ISH and PCR in addition to an immunohistochemical stain improves the diagnostic sensitivity in the detection of BM involvement and identification of clonality. Among the three different methods used, PCR is the most sensitive in detecting a minimal lesion.
Biopsy
;
Bone Marrow
;
Formaldehyde
;
Gene Rearrangement
;
Humans
;
In Situ Hybridization
;
Lymphoma*
;
Paraffin
;
Polymerase Chain Reaction
;
RNA, Messenger